Impact of the COVID-19 pandemic on Clostridioides difficile infection in a tertiary healthcare institution in Belgium.

Bastien TossensPhilippe BarthelmeCaroline BriquetLeila BelkhirEléonore NgyuvulaKate SoumillionAlexia VerrokenHector Rodriguez-VillalobosMichel DelméeAhalieyah Anantharajah

Published in: Acta clinica Belgica (2023)

The global decrease in CDI incidence observed in our hospital was not associated with a change in the use of antibiotics. The control measures implemented to prevent COVID-19 transmission may explain a reduction in CDI incidence. An underdiagnosis of CDI cannot be excluded.

Keyphrases

healthcare
risk factors
clostridium difficile
coronavirus disease
sars cov
acute care
drug induced
affordable care act